Cognyte Software Ltd. (CGNT) fair value analysis
Nasdaq · Updated 2026-10-19
CGNT price how computed
Valuation status
No verdict this weekCGNT: Next year's consensus is far above both what this company earned over the last four quarters and what its most recent quarter is earning.
Our model does not publish a verdict on a forecast that far from results; it is re-evaluated weekly.
- Last price
- $8.61
- Sector
- Technology
- 12-month range
- $6.34–$12.24
- Market cap
- $636M
- From 52-week high
- -29.7%
- Shares outstanding
- 73.8M
- Rank in Technology by quality score
- #152 of 274
Last price is our stored weekly price from 2026-10-16, older than the 2026-10-19 run that built this page; the chart runs through 2026-10-16.
Cognyte Software Ltd. is a technology company that develops and provides software solutions for investigations and intelligence gathering, serving government agencies, law enforcement, and enterprises worldwide. The company operates globally with offices and operations across multiple regions including North America, Europe, and Asia-Pacific.
CGNT currently ranks #152 of 274 Technology stocks by quality score.
Fundamentals (4 quarters) how computed
- Market cap
- $636M
- P/E (trailing)
- 36x
- Revenue (TTM)
- $422M
- Net margin
- -0.0%
- EPS (TTM)
- $0.24
- Gross margin
- 72.9%
- Debt / equity
- 0.18
- Revenue growth (3-yr avg)
- 12.5%
- Shares outstanding
- 73.8M
Derived indicators how computed
- Quality grade
- C
- Margin trend
- Expanding
- 52-week position
- The lower-middle quarter of its range
- DCF cross-check
- Overvalued
Technicals how computed
- RSI (14-day)
- 49 · neutral
- 50-day average
- $8.67
- 200-day average
- $8.83
- Moving-average state
- 50-day below 200-day (death cross state); price below both averages
Earnings how computed
- Next earnings report
- 2026-12-08
- Last 8 quarters vs consensus
- 7 beat, 1 missed
- Quarter by quarter
- 2026-07 ▲ beat (+700.0%)
2026-04 ▼ miss (-66.7%)
2026-01 ▲ beat (+200.3%)
2025-10 ▲ beat (+200.0%)
2025-07 ▲ beat (+166.7%)
2025-04 ▲ beat (+600.0%)
2025-01 ▲ beat (+200.0%)
2024-10 ▲ beat (+150.0%)
Analyst consensus how computed
This is not TickrTrends' verdict.
- Analyst ratings
- 2 buy · 2 hold · 0 sell (4 analysts)
- Consensus lean
- Buy-leaning
- Consensus price target
- $12.3
- Target vs last price
- +42.9%
What our data shows for CGNT
- Our model validated 7 trailing price-to-earnings windows for CGNT, built from quarterly earnings records.
- Shares are trading in the middle of their 12-month price range of $6.34–$12.24.
- The 14-day relative strength index sits at a neutral 49.
What subscribers see
- Every published Forward Fair Value with its exact discount or premium
- The normalized P/E and quarter count behind each estimate
- Screeners and rankings across the full S&P 500 and Nasdaq universes
- CGNT's own verdict the week it qualifies, published automatically
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
Recent CGNT news
TickrTrends' derived news-sentiment signal for CGNT is currently leaning positive, computed from recent coverage.
- Cognyte (CGNT) Secures $20M+ Defense Contract with NATO Ministry of Defense (gurufocus.com, 2026-10-21)
TickrTrends take: Cognyte's recent $20 million defense contract with NATO represents a significant revenue opportunity for the Technology sector company, which TickrTrends currently assesses as undervalued. For valuation-focused investors, the key metric to monitor will be how this contract impacts future quarterly revenue growth and whether the company can demonstrate sustained profitability expansion from government contracts. The durability and potential for contract renewal or expansion within NATO ministries could materially affect the company's intrinsic valuation relative to current market pricing. - CGNT Looks 12.0% Undervalued on GF Value™ (gurufocus.com, 2026-09-22)
TickrTrends take: Cogniant Corporation trades at a valuation discount according to GuruFocus analysis, which aligns with TickrTrends' current assessment that the technology stock appears undervalued. Investors focused on valuation metrics should monitor whether this gap persists or narrows as market conditions and company fundamentals evolve. The alignment between multiple valuation frameworks suggests the current pricing may warrant attention from value-oriented research portfolios tracking technology sector opportunities. - Cognyte (CGNT) Grew Total Software Revenue 21%. Can the Mix Offset Weak Billings? (insidermonkey.com, 2026-09-16)
TickrTrends take: Cognyte reported total software revenue growth of 21%, a positive indicator for a company currently assessed as undervalued by TickrTrends. However, the headline raises a question about billings weakness that investors focused on valuation should monitor, as strong revenue growth may mask underlying challenges in cash collection or customer purchasing patterns. For a technology company trading at undervalued levels, the ability to convert this revenue growth into solid billings figures will be important to watch in upcoming reports.
More CGNT news
- CGNT Looks 12.9% Undervalued on GF Value™ (gurufocus.com, 2026-09-15)
What people are saying
Follow the CGNT conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — TickrTrends' derived indicators for CGNT show a shift this week as the 50/200-day trend state moved from mixed to downtrend. Despite this technical deterioration, the current valuation verdict remains undervalued. The downtrend development suggests weakening price momentum in the near term, though the undervalued assessment indicates the stock may still present value considerations relative to fundamental metrics.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — # CGNT Weekly Summary TickrTrends' quality grade for CGNT improved from D to C this week, reflecting a positive shift in the company's derived indicators within the Technology sector. The stock maintains an undervalued valuation verdict according to current analysis.
- 2026-10-05 — TickrTrends' derived indicators for CGNT showed a shift in the 50/200-day trend state this week, moving from a downtrend to a mixed trend. The stock remains rated as undervalued based on current valuation metrics. This change in trend state suggests a potential stabilization in the stock's recent price momentum.
- 2026-09-28 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-21 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-17 — No material change this week: the verdict, bands and grades all held steady.
Frequently asked questions
Is CGNT stock undervalued?
CGNT does not yet have sufficient validated earnings history for a full Forward Fair Value verdict under TickrTrends' standards; it is re-evaluated every week.
What is CGNT's TickrTrends verdict?
CGNT is currently marked 'Awaiting full valuation' - a verdict publishes automatically once at least six validated trailing P/E windows accumulate.
How does CGNT compare to other Technology stocks?
CGNT ranks #152 of 274 Technology stocks in TickrTrends' coverage by quality score. It carries no fair-value verdict yet, so it is not ranked by discount.
Is CGNT overbought or oversold?
CGNT's 14-day RSI is in neutral territory - neither overbought nor oversold.
When does CGNT report earnings next?
CGNT's next earnings report is scheduled for 2026-12-08, per the published earnings calendar.
Does CGNT usually beat earnings estimates?
Over its last 8 reported quarters CGNT beat the consensus estimate 7 times and missed 1 times, by TickrTrends' comparison of reported and estimated EPS.
What do analysts say about CGNT?
Of 4 analysts covering CGNT, 2 rate it a buy, 2 a hold and 0 a sell - buy-leaning, with a consensus price target of $12.3 (+42.9% versus TickrTrends' last price). This is the analyst consensus, not TickrTrends' Forward Fair Value verdict.